The aquisition marks the fifth deal for Accelrys over the past two years, beginning with its $35 million buyout of Hopkinton, MA-based VelQuest and $30 million acquisition of Lafayette, CO-based Aegis Analytical Corp. in 2012. Accelrys bought the Swiss biosciences software company Vialis for $5 million and Fairfield, CA-based ChemSW for $15.3 million earlier this year.
Accelrys has about 640 employees worldwide, including 152 at its San Diego headquarters, according to a spokeswoman for the company. Qumas would add about 100 to the overall headcount, including 26 in the United States.
Accelrys provides scientific software and informatics technologies, which are used primarily in scientific research by industry and academic organizations. In recent years, the company has been expanding into product development and manufacturing, covering the entire lab-to-commercialization value chain. Accelry also is extending its reach beyond the pharmaceutical and biotech industries into such related industries as food and beverage, fine and specialty chemicals, oil and gas, and aerospace.
By integrating its enterprise software platform with more specialized scientific software applications, Accelrys says it is meeting customer demand to manage product development from benchtop to grave. The company says its approach ensures that its customers can manage their requirements for regulatory compliance and quality control more consistently across the entire product lifecycle.